Drucker D J, Jin T, Asa S L, Young T A, Brubaker P L
Department of Medicine, University of Toronto, Ontario, Canada.
Mol Endocrinol. 1994 Dec;8(12):1646-55. doi: 10.1210/mend.8.12.7535893.
The gene encoding proglucagon is expressed predominantly in the pancreas and intestine. The physiological importance of glucagon secreted from the islets of Langerhans has engendered considerable interest in the molecular control of proglucagon gene transcription in the endocrine pancreas. In contrast, little is known about the molecular control of proglucagon gene expression in the intestine. The recent demonstration that glucagon-like peptide-1 (GLP-1) secreted from the intestine is a potent regulator of insulin secretion and glucose homeostasis has stimulated renewed interest in the factors that control GLP-1 synthesis in the intestinal L-cell. To develop a model for the analysis of intestinal proglucagon gene expression, we have targeted expression of a proglucagon gene-simian virus-40 large T-antigen fusion gene to enteroendocrine cells in transgenic mice. These mice develop intestinal tumors that were used to derive a novel cell line, designated GLUTag, that expresses the proglucagon gene and secretes immunoreactive GLP-1 in vitro. GLUTag cells demonstrate morphological characteristics of enteroendocrine cells by electron microscopy and are plurihormonal, as shown by immunocytochemistry and RNA analyses. GLUTag cells express the proglucagon and cholecystokinin genes, consistent with the pattern of lineage-specific enteroendocrine differentiation described for mouse intestine. Proglucagon gene expression was induced by activators of the protein kinase-A pathway, and a combination of messenger RNA half-life and nuclear run-on experiments demonstrated that the protein kinase-A-induction is mediated by an increase in proglucagon gene transcription. In contrast, activators of protein kinase-C stimulated secretion, but not biosynthesis of the PGDPs in GLUTag cell cultures. Analysis of proglucagon processing in GLUTag cells demonstrated the liberation of glucagon, oxyntomodulin, glicentin, and multiple forms of GLP-1. These observations provide evidence for the direct induction of proglucagon gene transcription by a cAMP-dependent pathway and suggest that the GLUTag cell line represents a useful model for the analysis of the molecular determinants of enteroendocrine gene expression.
编码胰高血糖素原的基因主要在胰腺和肠道中表达。胰岛分泌的胰高血糖素的生理重要性引发了人们对内分泌胰腺中胰高血糖素原基因转录分子调控的浓厚兴趣。相比之下,对于肠道中胰高血糖素原基因表达的分子调控知之甚少。最近的研究表明,肠道分泌的胰高血糖素样肽-1(GLP-1)是胰岛素分泌和葡萄糖稳态的有效调节因子,这激发了人们对控制肠道L细胞中GLP-1合成的因素的新兴趣。为了建立一个分析肠道胰高血糖素原基因表达的模型,我们将胰高血糖素原基因-猿猴病毒40大T抗原融合基因的表达靶向到转基因小鼠的肠内分泌细胞中。这些小鼠会发生肠道肿瘤,利用这些肿瘤衍生出一种新的细胞系,命名为GLUTag,该细胞系在体外表达胰高血糖素原基因并分泌免疫反应性GLP-1。通过电子显微镜观察,GLUTag细胞表现出肠内分泌细胞的形态特征,免疫细胞化学和RNA分析表明其具有多种激素分泌功能。GLUTag细胞表达胰高血糖素原和胆囊收缩素基因,这与小鼠肠道中描述的谱系特异性肠内分泌分化模式一致。蛋白激酶-A途径的激活剂可诱导胰高血糖素原基因表达,信使RNA半衰期和细胞核连续转录实验表明,蛋白激酶-A诱导是通过胰高血糖素原基因转录增加介导的。相反,蛋白激酶-C的激活剂刺激了GLUTag细胞培养物中PGDPs的分泌,但不影响其生物合成。对GLUTag细胞中胰高血糖素原加工过程的分析表明,可释放出胰高血糖素、胃泌酸调节素、胰高血糖素原和多种形式的GLP-1。这些观察结果为cAMP依赖性途径直接诱导胰高血糖素原基因转录提供了证据,并表明GLUTag细胞系是分析肠内分泌基因表达分子决定因素的有用模型。